FOR UK HEALTHCARE PROFESSIONALS
For more information about Cetraxal®, please click here for prescribing information
Legal category: POM
Active substance: ciprofloxacin (2mg/ml)
By using the link below you will leave the Cetraxal website and be re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.
Legal category: POM
Active substance: ciprofloxacin + fluocinolone acetonide (3mg/ml + 0.25mg/ml)
By using the link below you will leave the Cetraxal website and be re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.
When AOE strikes, deploy Cetraxal
Adverse events should be reported. Reporting forms and information can be found at:
www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.
Revision reference – Cetraxal_4_17.11.2021
